Sugi Predict

Sugi Predict / Compounds / SCHEMBL607623

SCHEMBL607623

SCHEMBL607623

CCCCc1ccc(S(N)(=O)=O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 17/20 1.00
▸ SMN1; SMN2 Q16637 2/20 1.00
▸ CA1 P00915 10/20 0.71
▸ CA9 Q16790 9/20 0.71
▸ CA12 O43570 7/20 0.71
▸ CA7 P43166 4/20 0.62
▸ CA4 P22748 3/20 0.62
▸ CA6 P23280 3/20 0.62
▸ CA5A P35218 3/20 0.62
▸ CA14 Q9ULX7 3/20 0.62
▸ CA5B Q9Y2D0 3/20 0.62
▸ MEN1 O00255 1/20 0.61
▸ LMNA P02545 1/20 0.61
▸ MAPK1 P28482 1/20 0.61
▸ HTT P42858 1/20 0.61
▸ KMT2A Q03164 1/20 0.61
▸ HSD17B10 Q99714 1/20 0.60
▸ TSHR P16473 1/20 0.59
▸ ALDH1A1 P00352 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18122304 0.94 CA2 (0.89) CA2SMN1; SMN2CA1CA9CA12
SCHEMBL607046 0.94 CA2 (1.00) CA2SMN1; SMN2CA1CA9CA12
SCHEMBL17817182 0.92 CA2 (0.96) CA2SMN1; SMN2CA1CA9CA12
SCHEMBL7898294 0.92 CA2 (0.96) CA2SMN1; SMN2CA1CA9CA12
SCHEMBL28640316 0.92 CA2 (0.96) CA2SMN1; SMN2CA1CA9CA12
SCHEMBL9126817 0.92 CA2 (0.96) CA2SMN1; SMN2CA1CA9CA12
SCHEMBL78265 0.92 CA2 (0.96) CA2SMN1; SMN2CA1CA9CA12
SCHEMBL10661919 0.92 CA2 (0.96) CA2SMN1; SMN2CA1CA9CA12
SCHEMBL27829522 0.88 CA2 (0.78) CA2SMN1; SMN2CA1CA9CA12
SCHEMBL429778 0.88 CA2 (1.00) CA2SMN1; SMN2CA1CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10201957-B2 Dye receiving layer composition, dye receiving substrate and method of fabricating the same CHIEN HWA COATING TECHNOLOGY , INC. (TW) 2019-02-12 — — US claimed
EP-3363650-A1 DYE RECEIVING LAYER COMPOSITION, DYE RECEIVING SUBSTRATE AND METHOD OF FABRICATING THE SAME Chien Hwa Coating Technology, Inc. (TW) 2018-08-22 — — EP claimed
CN-108084704-A A kind of antistatic anti-aging plastic shell 贵州博裕电子科技有限公司 2018-05-29 — — CN claimed
CN-108084703-A A kind of production method of antistatic anti-aging plastic shell 贵州博裕电子科技有限公司 2018-05-29 — — CN claimed
CN-106832578-A A kind of automobile storage battery tank material with flame retardant effect and preparation method thereof 芜湖天鸿汽车零部件有限公司 2017-06-13 — — CN claimed
US-20110144033-A1 Proteasome Inhibitors and Methods of Using the Same CEPHALON, INC. (US) 2011-06-16 — — US claimed
US-7915236-B2 Proteasome inhibitors and methods of using the same CEPHALON, INC. (US) 2011-03-29 — — US claimed
EP-1660507-B9 PROTEASOME INHIBITORS AND METHODS OF USING THE SAME CEPHALON INC (US) 2010-03-24 — — EP claimed
US-20090291918-A1 PROTEASOME INHIBITORS AND METHODS OF USING THE SAME CEPHALON, INC. (US) 2009-11-26 — — US claimed
EP-1660507-B1 PROTEASOME INHIBITORS AND METHODS OF USING THE SAME CEPHALON INC (US) 2009-08-05 — — EP claimed
CN-1867572-A proteasome inhibitors and methods of use thereof CEPHALON INC (US) 2006-11-22 — — CN claimed
US-20050107307-A1 Proteasome inhibitors and methods of using the same TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-05-19 — — US claimed
EP-0856565-B1 Ink composition for a meltable ink OCE TECH BV (NL) 2004-04-28 — — EP claimed
US-6071986-A USABLE IN PRINTING DEVICES IN WHICH INK DROPLETS ARE EJECTED FROM DUCTS; FLOW AND SETTING PROPERTIES AND THE STIFFNESS OF THE INK CAN BE ADJUSTED BY THE CHOICE AND RELATIVE PROPORTION OF THE CONSTITUENTS OCE-TECHNOLOGIES, B.V. (NL) 2000-06-06 — — US claimed
EP-0856565-A1 Ink composition for a meltable ink Océ-Technologies B.V. (NL) 1998-08-05 — — EP claimed
WO-1996013372-A2 BUILD MATERIAL FOR FORMING A THREE DIMENSIONAL ARTICLE BPM TECHNOLOGY, INC. (US) 1996-05-09 — — WO claimed
US-4874894-A Process for the production of benzenesulfonamides HILTON DAVIS CO. (US) 1989-10-17 — — US claimed
CN-119838435-B Composite reverse osmosis membrane and preparation method thereof 湖南沁森高科新材料有限公司 2025-05-23 — — CN disclosed
US-4874894-A Process for the production of benzenesulfonamides HILTON DAVIS CO. (US) 1989-10-17 — — US disclosed
US-4820346-A Ink jet printer ink HOWTEK, INC. (US) 1989-04-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291918-A1 PROTEASOME INHIBITORS AND METHODS OF USING THE SAME PSMB11, PSMB5, PSMB6 CA2 2765/4885SMN1; SMN2 1107/4885CA1 902/4885
US-20050107307-A1 Proteasome inhibitors and methods of using the same PSMB11, PSMB5, PSMB6 CA2 2765/4885SMN1; SMN2 1107/4885CA1 902/4885
US-20110144033-A1 Proteasome Inhibitors and Methods of Using the Same PSMB11, PSMB5, PSMB6 CA2 2765/4885SMN1; SMN2 1107/4885CA1 902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.